Agenus

Assay Development & Screening (75-100%) Senior Research Associate / Scientist

UK-Cambridge
2 months ago
ID
2017-1292
Category
Research

Overview

Agenus is a pioneer in the emerging field of Immuno-oncology. For two decades, Agenus has been creating and advancing patient-specific anticancer vaccines in the effort to harness the power of the immune system to control or eradicate cancer. We now have a portfolio of innovative approaches that include checkpoint modulators, personalized anticancer vaccines and powerful adjuvants. We are dedicated scientists, researchers, biotechnologists, physicians, and businesspeople working together toward one goal: minimize the burden of cancers and infections by helping the body heal itself through the power of science.

 

The work we do at Agenus is cutting edge and deeply motivating. We believe passionately in our technology, in our pipeline, and in our responsibility to deliver on the promise of immunology to treat cancer and infectious disease. Our environment fosters innovation and leadership at every level. We encourage people to think and dream big. We provide the opportunity to apply your many talents and develop your career in creative and sometimes unconventional ways. If you’re looking for an inspired environment, passionate colleagues, and a culture that nurtures learning, innovation and team success, we invite you to join us.

 

 

We have an exciting opportunity for a Senior Research Associate/Scientist I (one-year temporary position with possibility of extension) to join the Antibody Discovery group in our recently established R&D facility in Cambridge. This role can either be part or full-time, ranging from 75-100%-Please state your preferred working time in your application)

As a Scientist within the Assay Development and Screening Team you will contribute to advancing innovative technologies and projects to support the generation of therapeutic biologics in the Immuno-Oncology field.

Responsibilities

  • Contribute to project progression by using biochemical and cell-based screening assays to identify antibodies with characteristics meeting the Therapeutic Target Profile.
  • Develop, evaluate, optimize and implement novel technologies and methods for process improvement.
  • Play a key role in the decision-making process to select best antibody candidates to take forward.
  • Expected to work independently liaising closely with colleagues within the project team and across functional groups. Maintain clear and efficient communication.
  • Collate results, manage antibody data within the project and contribute to report where applicable.
  • Maintain a current and accurate laboratory record (lab notebook) of all activities.
  • Expected to give regular presentations.
  • Understand and adhere to corporate standards regarding code of conduct, safety, appropriate handling of materials.

Qualifications

  • MSc with >5-7 years industrial experience or PhD in a biological science/biochemistry discipline.

Experience

  • Experience with biochemical assays such as ELISA, Luminex, HTRF, mirrorball or alphascreen
  • Practical knowledge of working with mammalian cell culture techniques
  • Experience with cell-based assays e.g. reporter assays, flow cytometry, mediator release
  • Determination of drug EC50 and IC50
  • Experience of using BIAcore for affinity determination and/or screening would be an advantage
  • Molecular biology and cell culture skills for making transient and stable cell lines is a bonus
  • Experience in an industrial setting is desirable

 

Profile

  • Ability to work independently and in a team
  • Highly autonomous and productive in performing laboratory experiments or method development
  • Outstanding organizational and multi-tasking skills; ability to manage several projects simultaneously and to adjust to changing priorities
  • Excellent analytical skills and capacity to analyse large amount of data, good attention to details
  • Excellent communication skills with presentation of work and data as well as sharing experience with others

 

Options

Sorry the Share function is not working properly at this moment. Please refresh the page and try again later.
Share on your newsfeed